Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Recombinant human IL-1β Diverse viral proteases activate the NLRP1 inflammasome. 2021 Elife Tsu B.T. et al. DOI: 10.7554/eLife.60609
Human IL-1α & IL-1β Reporter HEK 293 Cells Diverse viral proteases activate the NLRP1 inflammasome. 2021 Elife Tsu B.T. et al. DOI: 10.7554/eLife.60609
QUANTI-Blue™ Diverse viral proteases activate the NLRP1 inflammasome. 2021 Elife Tsu B.T. et al. DOI: 10.7554/eLife.60609
TLR4 agonist preparation - MPLA-SM Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific ... 2021 Front Immunol Jansen M.A. et al. DOI: 10.3389/fimmu.2019.02068
J774-Dual™ Cells Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
LyoVec™ Inhibitor of growth protein 3 epigenetically silences endogenous retroviral e... 2021 Nucleic Acids Res Song Y. et al. DOI: 10.1093/nar/gkab1070
Poly(I:C) (HMW) / LyoVec™ Inhibitor of growth protein 3 epigenetically silences endogenous retroviral e... 2021 Nucleic Acids Res Song Y. et al. DOI: 10.1093/nar/gkab1070
Recombinant human IFN-α Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
QUANTI-Luc™: Luciferase Detection Reagent Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
5'ppp-dsRNA Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
THP1-Dual™ Cells Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
QUANTI-Blue™ Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
2'3'-cGAMP Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy ris... 2021 J Immunother Cancer Sprooten J. et al. DOI: 10.1136/jitc-2021-003609
MycoStrip® - Mycoplasma Detection Kit MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis. 2021 PLoS One Shin G.T. et al. DOI: 10.1371/journal.pone.0260135
Puromycin MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis. 2021 PLoS One Shin G.T. et al. DOI: 10.1371/journal.pone.0260135
ODN D-SL03 An allergen-fused dendritic cell-binding peptide enhances in vitro proliferat... 2022 Vet Immunol Immunopathol Ziegler A et al. DOI: 10.1016/j.vetimm.2021.110351
TLR4 agonist preparation - MPLA-SM An allergen-fused dendritic cell-binding peptide enhances in vitro proliferat... 2022 Vet Immunol Immunopathol Ziegler A et al. DOI: 10.1016/j.vetimm.2021.110351
WGP - Whole Glucan Particles Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal infla... 2021 Nat Commun Ryzhakov G. et al. DOI: 10.1038/s41467-021-27038-5
Puromycin Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal infla... 2021 Nat Commun Ryzhakov G. et al. DOI: 10.1038/s41467-021-27038-5
Recombinant anti-mouse PD-1 antibody - Clone RMP1-14 (D265A) Sharpening up tumor microenvironment to enhance the efficacy of immune checkp... 2021 Cancer Immunol Immunother Tseng J.C. et al. DOI: 10.1007/s00262-021-03062-8

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty